These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12516768)

  • 1. Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine model.
    Aiba Y; Ishikawa H; Shimizu K; Noda S; Kitada Y; Sasaki M; Koga Y
    Microbiol Immunol; 2002; 46(11):723-31. PubMed ID: 12516768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.
    Asahara T; Shimizu K; Nomoto K; Hamabata T; Ozawa A; Takeda Y
    Infect Immun; 2004 Apr; 72(4):2240-7. PubMed ID: 15039348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic Shiga toxin-producing Escherichia coli in the intestine of calves.
    Sandhu KS; Gyles CL
    Can J Vet Res; 2002 Apr; 66(2):65-72. PubMed ID: 11989736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
    Yoshimura K; Matsui T; Itoh K
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.
    Ogawa M; Shimizu K; Nomoto K; Takahashi M; Watanuki M; Tanaka R; Tanaka T; Hamabata T; Yamasaki S; Takeda Y
    Infect Immun; 2001 Feb; 69(2):1101-8. PubMed ID: 11160007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli.
    Paton JC; Rogers TJ; Morona R; Paton AW
    Infect Immun; 2001 Mar; 69(3):1389-93. PubMed ID: 11179303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
    Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
    Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Selenium Nanoparticle-Enriched Lactobacilli Feeding Against Escherichia coli O157:H7 Infection of BALB/c Mice.
    Esfandiari Z; Vakili B; Ahangarzadeh S; Esfahani SN; Shoaei P
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):784-795. PubMed ID: 37145299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, quantification and isolation of pathogenic shiga toxin Escherichia coli O157:H7 along the production and supply chain of pork around Hubei Province of China.
    Khan SB; Zou G; Xiao R; Cheng Y; Rehman ZU; Ali S; Memon AM; Fahad S; Ahmad I; Zhou R
    Microb Pathog; 2018 Feb; 115():93-99. PubMed ID: 29273508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
    Carey CM; Kostrzynska M; Ojha S; Thompson S
    J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection.
    Cabrera G; Fernández-Brando RJ; Mejías MP; Ramos MV; Abrey-Recalde MJ; Vanzulli S; Vermeulen M; Palermo MS
    Int J Med Microbiol; 2015 Dec; 305(8):910-7. PubMed ID: 26456732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of O157:H7, O26:H11 and O103:H2 Shiga toxin-producing Escherichia coli isolated from dairy products.
    Douëllou T; Delannoy S; Ganet S; Fach P; Loukiadis E; Montel MC; Sergentet-Thevenot D
    Int J Food Microbiol; 2017 Jul; 253():59-65. PubMed ID: 28499121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of enterohemorrhagic Escherichia coli (EHEC) in cattle].
    Mercado EC
    Medicina (B Aires); 2006; 66 Suppl 3():33-6. PubMed ID: 17354475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of probiotics to reduce faecal shedding of Shiga toxin-producing Escherichia coli in sheep.
    Rigobelo EE; Karapetkov N; Maestá SA; Avila FA; McIntosh D
    Benef Microbes; 2015 Mar; 6(1):53-60. PubMed ID: 25380795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Shiga toxin-producing Escherichia coli in pasture-based dairy herds.
    Ross CM; Rapp D; Cave VM; Brightwell G
    Lett Appl Microbiol; 2019 Feb; 68(2):112-119. PubMed ID: 30411807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity of Shiga toxin-producing Escherichia coli strains isolated in Sao Paulo, Brazil, from 1976 through 2003, as revealed by pulsed-field gel electrophoresis.
    Vaz TM; Irino K; Nishimura LS; Cergole-Novella MC; Guth BE
    J Clin Microbiol; 2006 Mar; 44(3):798-804. PubMed ID: 16517857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin producing Escherichia coli infection: current progress & future challenges.
    Khan A; Datta S; Das SC; Ramamurthy T; Khanam J; Takeda Y; Bhattacharya SK; Nair GB
    Indian J Med Res; 2003 Jul; 118():1-24. PubMed ID: 14748461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli.
    Reissbrodt R; Hammes WP; dal Bello F; Prager R; Fruth A; Hantke K; Rakin A; Starcic-Erjavec M; Williams PH
    FEMS Microbiol Lett; 2009 Jan; 290(1):62-9. PubMed ID: 19016876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
    Werber D; Fruth A; Buchholz U; Prager R; Kramer MH; Ammon A; Tschäpe H
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):726-30. PubMed ID: 14614596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.